344 related articles for article (PubMed ID: 30928177)
1. Dosimetric comparison of intensity-modulated radiation therapy for early-stage glottic cancers with and without the air cavity in the planning target volume.
Asher D; Amestoy W; Studenski MT; Samuels SE; Abramowitz MC; Freedman LM; Elsayyad N; Samuels MA
Med Dosim; 2019 Winter; 44(4):405-408. PubMed ID: 30928177
[TBL] [Abstract][Full Text] [Related]
2. Evaluating different radiotherapy treatment plans, in terms of critical organ scoring index, conformity index, tumor control probability, and normal tissue complication probability calculations in early glottic larynx carcinoma.
Inal A; Duman E; Ozkan EE
J Cancer Res Ther; 2020; 16(3):485-493. PubMed ID: 32719255
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric effect of intensity-modulated radiation therapy for postoperative non-small cell lung cancer with and without air cavity in the planning target volume.
Gan W; Duan Y; Wang H; Shao Y; Chen H; Feng A; Gu H; Huang Y; Ying Y; Fu X; Quan H; Xu Z
Med Dosim; 2022 Spring; 47(1):32-37. PubMed ID: 34551878
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison of helical tomotherapy, intensity-modulated radiation therapy, volumetric-modulated arc therapy, and 3-dimensional conformal therapy for the treatment of T1N0 glottic cancer.
Ekici K; Pepele EK; Yaprak B; Temelli O; Eraslan AF; Kucuk N; Altınok AY; Sut PA; Alpak OD; Colak C; Mayadagli A
Med Dosim; 2016 Winter; 41(4):329-333. PubMed ID: 27765542
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison between carotid-sparing IMRT and 3DCRT in early glottic cancer patients treated with definitive radiation therapy.
Kaur H; Thakur N; Sharma R; Sudan M; Jain N; Kaur S; Lehal P
J Cancer Res Ther; 2024 Jan; 20(1):327-332. PubMed ID: 38554342
[TBL] [Abstract][Full Text] [Related]
6. Carotid-Sparing TomoHelical 3-Dimensional Conformal Radiotherapy for Early Glottic Cancer.
Hong CS; Oh D; Ju SG; Ahn YC; Noh JM; Chung K; Kim JS; Suh TS
Cancer Res Treat; 2016 Jan; 48(1):63-70. PubMed ID: 25761477
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
8. Volumetric modulated arc therapy with robust optimization for larynx cancer.
Miura H; Doi Y; Ozawa S; Nakao M; Ohnishi K; Kenjo M; Nagata Y
Phys Med; 2019 Feb; 58():54-58. PubMed ID: 30824150
[TBL] [Abstract][Full Text] [Related]
9. Use of volumetric modulated arc radiotherapy in patients with early stage glottic cancer.
Atalar B; Gungor G; Caglar H; Aydin G; Yapici B; Ozyar E
Tumori; 2012; 98(3):331-6. PubMed ID: 22825509
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric and radiobiologic comparison of 3D conformal, IMRT, VMAT and proton therapy for the treatment of early-stage glottic cancer.
Matthiesen C; Herman Tde L; Singh H; Mascia A; Confer M; Simpson H; Higby C; Arain A; Keole S; Herman T; Bogardus C; Zhao YD; Ahmad S
J Med Imaging Radiat Oncol; 2015 Apr; 59(2):221-8. PubMed ID: 25146003
[TBL] [Abstract][Full Text] [Related]
11. A dosimetric comparison of the use of equally spaced beam (ESB), beam angle optimization (BAO), and volumetric modulated arc therapy (VMAT) in head and neck cancers treated by intensity modulated radiotherapy.
Leung WS; Wu VWC; Liu CYW; Cheng ACK
J Appl Clin Med Phys; 2019 Nov; 20(11):121-130. PubMed ID: 31593367
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.
Hong L; Alektiar KM; Hunt M; Venkatraman E; Leibel SA
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):752-9. PubMed ID: 15183478
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric Evaluation of Different Intensity-Modulated Radiotherapy Techniques for Breast Cancer After Conservative Surgery.
Zhang F; Wang Y; Xu W; Jiang H; Liu Q; Gao J; Yao B; Hou J; He H
Technol Cancer Res Treat; 2015 Oct; 14(5):515-23. PubMed ID: 25311257
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma.
Hung HM; Chan OCM; Mak CH; Hung WM; Ng WT; Lee MCH
Med Dosim; 2022 Spring; 47(1):14-19. PubMed ID: 34470708
[TBL] [Abstract][Full Text] [Related]
16. Impact of dose calculation accuracy during optimization on lung IMRT plan quality.
Li Y; Rodrigues A; Li T; Yuan L; Yin FF; Wu QJ
J Appl Clin Med Phys; 2015 Jan; 16(1):5137. PubMed ID: 25679172
[TBL] [Abstract][Full Text] [Related]
17. Can carotid-sparing radiotherapy approaches replace with conventional techniques for the patients with T1 glottic larynx cancer?
Sert F; Karakoyun-Çelik O; Esassolak MA
Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):267-74. PubMed ID: 22991987
[TBL] [Abstract][Full Text] [Related]
18. Improving target dose coverage and organ-at-risk sparing in intensity-modulated radiotherapy of advanced laryngeal cancer by a simple optimization technique.
Lu JY; Wu LL; Zhang JY; Zheng J; Cheung ML; Ma CC; Xie LX; Huang BT
Br J Radiol; 2015 Feb; 88(1046):20140654. PubMed ID: 25494885
[TBL] [Abstract][Full Text] [Related]
19. Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer.
Outaggarts Z; Wegener D; Berger B; Zips D; Paulsen F; Bleif M; Thorwarth D; Alber M; Dohm O; Müller AC
Acta Oncol; 2020 Aug; 59(8):911-917. PubMed ID: 32436467
[No Abstract] [Full Text] [Related]
20. Preliminary Simulation Study of Carotid Artery and Pharyngeal Constrictor Muscle Sparing-Radiotherapy in Glottic Carcinoma.
Ozdemir Y; Acibuci I; Selek U; Topkan E
Technol Cancer Res Treat; 2020; 19():1533033820956989. PubMed ID: 33034277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
